Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE) — Stella

Home/Marginal Zone Lymphoma/

View on ClinicalTrials.gov

Recruiting

Back to Marginal Zone Lymphoma trials

Trial locations(1 site)

China

Shanghai Ruijin Hospital, Shanghai, Shanghai Municipality

Key details

Sponsor

Ruijin Hospital

Enrollment target

~500 participants

Started

August 2024

Primary completion

March 2029

Age range

14 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.